In Vitro Fertilization (IVF) Market - Global Industry Analysis

Brand: Zion Market Research
SKU: ZMR-964
Price: 4199.00 USD
Availability: InStock
Rating: 4.4 (89 reviews)

In Vitro Fertilization (IVF) Market by Product Type (Instruments [Cryosystem, Incubators, Imaging system, Ovum Aspiration Pump, Cabinet, Micro Manipulator System, Sperm Separation System, Disposables and Accessories, and Other Instruments] and Reagent & Media [Cryopreservation Media, Ovum Processing Media, Semen Processing Media, and Embryo Culture Media]); by Cycle Type (Fresh Donor IVF Cycles, Fresh Non-donor IVF Cycles, Frozen Donor IVF Cycles, and Frozen Non-donor IVF Cycles) : Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Published Date: 20-Jul-2018 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-964 Status : Published

Global in vitro fertilization (IVF) market expected to generate revenue of around USD 920.32 million by end of 2024, growing at a CAGR of around 8.40% between 2018 and 2024. In-vitro fertilization is a technique of fertilizing the egg by the sperm outside the body.

Request For Customization Request Free Brochure Request Free Sample Buy Now

Description

The report covers forecast and analysis for the in vitro fertilization (IVF) market on a global and regional level. The study provides historic data of 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the in vitro fertilization (IVF) market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the in vitro fertilization (IVF) market on a global level.

In order to give the users of this report a comprehensive view of the in vitro fertilization (IVF) market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein the product type segment, and cycle type segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global In Vitro Fertilization (IVF) Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers the key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research& development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.

The study provides a decisive view of the in vitro fertilization (IVF) market by segmenting the market based on product type, cycle type, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. Based on product type, the in vitro fertilization (IVF) market is segmented into instruments and reagent & media. The instruments segment is further sub-segmented into cryosystem, incubators, imaging system, ovum aspiration pump, cabinet, micromanipulator system, sperm separation system, disposables and accessories, and other instruments. The reagent & media segment is again further segmented into cryopreservation media, ovum processing media, semen processing media, and embryo culture media. On the basis of cycle type, the market is segmented fresh donor IVF cycles, fresh non-donor IVF cycles, frozen donor IVF cycles, and frozen non-donor IVF cycles. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further division into major countries including the U.S., the U.K., Germany, France, Italy, Spain, China, Japan, India, Brazil, GCC Countries, and other countries. This segmentation includes demand for in vitro fertilization (IVF) market based on individual product type, cycle type in all the regions and countries.

The report also includes detailed profiles of end players such as Cooper Surgical, Inc., Thermo Fisher Scientific, Vitrolife, Cook, Irvine Scientific, EMD Serono, Inc., Genea Limited, Esco Group, Rocket Medical plc., Nidacon International AB, Lotus Bio, Eppendorf AG, Okolab Srl, IKS International, Hunter Scientific Limited, Labotect GmbH, Olympus Corporation, and RI.MOS. Srl.

This report segments the global in vitro fertilization (IVF) market as follows:

Global In Vitro Fertilization (IVF) Market: Product Type Segment Analysis

By Instruments
- Cryosystem
- Incubators
- Imaging system
- Ovum Aspiration Pump
- Cabinet
- Micro Manipulator System
- Sperm Separation System
- Disposables and Accessories
- Others
Reagent & Media
- Cryopreservation Media
- Ovum Processing Media
- Semen Processing Media
- Embryo Culture Media

Global In Vitro Fertilization (IVF) Market: Cycle Type Segment Analysis

Fresh Donor IVF Cycles
Fresh Non-Donor IVF Cycles
Frozen Donor IVF Cycles
Frozen Non-Donor IVF Cycles

Global In Vitro Fertilization (IVF) Market: Regional Segment Analysis

North America
- The U.S.
Europe
- UK
- France
- Germany
Asia Pacific
- China
- Japan
- India
Latin America
- Brazil
Middle East and Africa

Table Of Content

Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
  - 1.3.1. Market research process
  - 1.3.2. Market research methodology
Chapter 2. Executive Summary
- 2.1. Global in vitro fertilization (IVF) market, 2017 - 2024(USD Million)
- 2.2. Global in vitro fertilization (IVF) market: snapshot
Chapter 3. In Vitro Fertilization (IVF) Market- Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
  - 3.2.1. Global In Vitro Fertilization (IVF) market drivers: impact analysis
  - 3.2.2. Delayed pregnancies in women and decreasing Fertility Rates
  - 3.2.3. Rising male infertility and changing lifestyle pattern
  - 3.2.4. Growing public awareness about infertility and the available treatment options
  - 3.2.5. Government initiatives to promote IVF treatments
  - 3.2.6. Introduction of new and advanced products
  - 3.2.7. Rise in disposable income
- 3.3. Market Restraints
  - 3.3.1. Global in vitro fertilization (IVF) market restraints: impact analysis
  - 3.3.2. Low success rate and high cost of the IVF treatment
  - 3.3.3. Multiple pregnancies
  - 3.3.4. Restrictive regulations and ethical concerns
- 3.4. Opportunities
  - 3.4.1. Rising research & development activity for in vitro fertilization (IVF) products
  - 3.4.2. Fertility Tourism
  - 3.4.3. Growing number of fertility clinics
- 3.5. Porter's five forces analysis
  - 3.5.1. Bargaining power of suppliers
  - 3.5.2. Bargaining power of buyers
  - 3.5.3. Threat from new entrants
  - 3.5.4. Threat from new substitutes
  - 3.5.5. Degree of competition
- 3.6. Market Attractiveness Analysis
  - 3.6.1. Market attractiveness analysis, by product type segment
  - 3.6.2. Market attractiveness analysis, by cycle type segment
  - 3.6.3. Market attractiveness analysis, by regional segment
Chapter 4. Global In Vitro Fertilization (IVF) Market- Competitive Landscape
- 4.1. Company market share analysis
  - 4.1.1. Global in vitro fertilization (IVF) market: company market share, 2017
- 4.2. Strategic development
  - 4.2.1. Acquisitions & mergers
  - 4.2.2. New therapy launch
  - 4.2.3. Agreements, partnerships, collaborations and joint ventures
  - 4.2.4. Research and development and regional expansion
Chapter 5. Global In Vitro Fertilization (IVF) Market- Product Type Segment Analysis
- 5.1. Global In Vitro Fertilization (IVF) market: product overview
  - 5.1.1. Global In Vitro Fertilization (IVF) market revenue share, by product type, 2017 and 2024
- 5.2. Instruments
  - 5.2.1. Global In Vitro Fertilization (IVF) market for Instruments, 2017 - 2024(USD Million)
  - 5.2.2. Cryosystem, In Vitro Fertilization (IVF) market for Instruments, 2017 - 2024(USD Million)
  - 5.2.3. Incubators, In Vitro Fertilization (IVF) market for Instruments, 2017 - 2024 (USD Million)
  - 5.2.4. Imaging system, In Vitro Fertilization (IVF) market for Instruments, 2017 - 2024 (USD Million)
  - 5.2.5. Ovum Aspiration Pump, In Vitro Fertilization (IVF) market for Instruments, 2017 - 2024 (USD Million)
  - 5.2.6. Cabinet, In Vitro Fertilization (IVF) market for Instruments, 2017 - 2024 (USD Million)
  - 5.2.7. Micro Manipulator System, In Vitro Fertilization (IVF) market for Instruments, 2017 - 2024 (USD Million)
  - 5.2.8. Sperm Separation System, In Vitro Fertilization (IVF) market for Instruments, 2017 - 2024 (USD Million)
  - 5.2.9. Disposables and Accessories, In Vitro Fertilization (IVF) market for Instruments, 2017 - 2024 (USD Million)
  - 5.2.10. Others ,In Vitro Fertilization (IVF) market for Instruments, 2017 - 2024(USD Million)
- 5.3. Reagent & Media
  - 5.3.1. Global In Vitro Fertilization (IVF) market for Reagent & Media, 2017 - 2024 (USD Million)
  - 5.3.2. Cryopreservation Media, In Vitro Fertilization (IVF) market for Reagent & Media, 2017 - 2024 (USD Million)
  - 5.3.3. Ovum Processing Media , In Vitro Fertilization (IVF) market for Reagent & Media, 2017 - 2024 (USD Million)
  - 5.3.4. Semen Processing Media , In Vitro Fertilization (IVF) market for Reagent & Media, 2017 - 2024 (USD Million)
  - 5.3.5. Embryo Culture Media , In Vitro Fertilization (IVF) market for Reagent & Media, 2017 - 2024 (USD Million)
Chapter 6. Global In Vitro Fertilization (IVF) Market- Cycle type Segment Analysis
- 6.1. Global In Vitro Fertilization (IVF) market: form type overview
  - 6.1.1. Global In Vitro Fertilization (IVF) market revenue share, by cycle type, 2017 and 2024
- 6.2. Fresh Donor IVF Cycles
  - 6.2.1. Global In Vitro Fertilization (IVF) market for Fresh Donor IVF Cycles, 2017 - 2024 (USD Million)
- 6.3. Fresh Non-donor IVF Cycles
  - 6.3.1. Global In Vitro Fertilization (IVF) market for Fresh Non-donor IVF Cycles, 2017 - 2024 (USD Million)
- 6.4. Frozen Donor IVF Cycles
  - 6.4.1. Global In Vitro Fertilization (IVF) market for Frozen Donor IVF Cycles ,2017 - 2024 (USD Million)
- 6.5. Frozen Non-donor IVF Cycles
  - 6.5.1. Global In Vitro Fertilization (IVF) market for Frozen Non-Donor IVF Cycles ,2017 - 2024 (USD Million)
Chapter 7. Global In Vitro Fertilization (IVF) Market- Regional Segment Analysis
- 7.1. Global In Vitro Fertilization (IVF) market: regional overview
  - 7.1.1. Global In Vitro Fertilization (IVF) market revenue share, by region, 2017 and 2024
- 7.2. North America
  - 7.2.1. North America In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
  - 7.2.2. North America In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
  - 7.2.3. U.S.
    - 7.2.3.1. U.S. In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
    - 7.2.3.2. U.S. In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
  - 7.2.4. Rest of North America
    - 7.2.4.1. Rest of North America In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
    - 7.2.4.2. Rest of North America In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
- 7.3. Europe
  - 7.3.1. Europe In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
  - 7.3.2. Europe In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
  - 7.3.3. U.K.
    - 7.3.3.1. U.K. In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024 (USD Million)
    - 7.3.3.2. U.K. In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024 (USD Million)
  - 7.3.4. Germany
    - 7.3.4.1. Germany In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
    - 7.3.4.2. Germany In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
  - 7.3.5. France
    - 7.3.5.1. France In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
    - 7.3.5.2. France In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
  - 7.3.6. Italy
    - 7.3.6.1. Italy In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
    - 7.3.6.2. Italy In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
  - 7.3.7. Spain
    - 7.3.7.1. Spain In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
    - 7.3.7.2. Spain In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
  - 7.3.8. Rest of Europe
    - 7.3.8.1. Rest of Europe In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
    - 7.3.8.2. Rest of Europe In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
- 7.4. Asia Pacific
  - 7.4.1. Asia Pacific In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024 (USD Million)
  - 7.4.2. Asia Pacific In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
  - 7.4.3. China
    - 7.4.3.1. China In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
    - 7.4.3.2. China In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
  - 7.4.4. Japan
    - 7.4.4.1. Japan In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
    - 7.4.4.2. Japan In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
  - 7.4.5. India
    - 7.4.5.1. India In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
    - 7.4.5.2. India In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
  - 7.4.6. Southeast Asia
    - 7.4.6.1. Southeast Asia In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
    - 7.4.6.2. Southeast Asia In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
  - 7.4.7. Rest of Asia Pacific
    - 7.4.7.1. Rest of Asia Pacific In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
    - 7.4.7.2. Rest of Asia Pacific In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
- 7.5. Latin America
  - 7.5.1. Latin America In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
  - 7.5.2. Latin America In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
  - 7.5.3. Brazil
    - 7.5.3.1. Brazil In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
    - 7.5.3.2. Brazil In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
  - 7.5.4. Rest of Latin America
    - 7.5.4.1. Rest of Latin America In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
    - 7.5.4.2. Rest of Latin America In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
- 7.6. Middle East and Africa
  - 7.6.1. Middle East and Africa In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
  - 7.6.2. Middle East and Africa In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
  - 7.6.3. GCC Countries
    - 7.6.3.1. GCC Countries In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
    - 7.6.3.2. GCC Countries In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
  - 7.6.4. Rest of Middle East and Africa
    - 7.6.4.1. Rest of Middle East and Africa In Vitro Fertilization (IVF) market revenue, by product type, 2017 - 2024(USD Million)
    - 7.6.4.2. Rest of Middle East and Africa In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 - 2024(USD Million)
Chapter 8. Company Profile
- 8.1. CooperSurgical, Inc.
  - 8.1.1. Overview
  - 8.1.2. Financials
  - 8.1.3. Product portfolio
  - 8.1.4. Business strategy
  - 8.1.5. Recent developments
- 8.2. Thermo Fisher Scientific
  - 8.2.1. Overview
  - 8.2.2. Financials
  - 8.2.3. Product portfolio
  - 8.2.4. Business strategy
  - 8.2.5. Recent developments
- 8.3. Vitrolife, Cook
  - 8.3.1. Overview
  - 8.3.2. Financials
  - 8.3.3. Product portfolio
  - 8.3.4. Business strategy
  - 8.3.5. Recent developments
- 8.4. Irvine Scientific
  - 8.4.1. Overview
  - 8.4.2. Financials
  - 8.4.3. Product portfolio
  - 8.4.4. Business strategy
  - 8.4.5. Recent developments
- 8.5. EMD Serono, Inc.
  - 8.5.1. Overview
  - 8.5.2. Financials
  - 8.5.3. Product portfolio
  - 8.5.4. Business strategy
  - 8.5.5. Recent developments
- 8.6. Genea Limited
  - 8.6.1. Overview
  - 8.6.2. Financials
  - 8.6.3. Product portfolio
  - 8.6.4. Business strategy
  - 8.6.5. Recent developments
- 8.7. Esco Group
  - 8.7.1. Overview
  - 8.7.2. Financials
  - 8.7.3. Product portfolio
  - 8.7.4. Business strategy
  - 8.7.5. Recent developments
- 8.8. Rocket Medical plc.
  - 8.8.1. Overview
  - 8.8.2. Financials
  - 8.8.3. Product portfolio
  - 8.8.4. Business strategy
  - 8.8.5. Recent developments
- 8.9. Nidacon International AB
  - 8.9.1. Overview
  - 8.9.2. Financials
  - 8.9.3. Product portfolio
  - 8.9.4. Business strategy
  - 8.9.5. Recent developments
- 8.10. Lotus Bio
  - 8.10.1. Overview
  - 8.10.2. Financials
  - 8.10.3. Product portfolio
  - 8.10.4. Business strategy
  - 8.10.5. Recent developments
- 8.11. Eppendorf AG
  - 8.11.1. Overview
  - 8.11.2. Financials
  - 8.11.3. Product portfolio
  - 8.11.4. Business strategy
  - 8.11.5. Recent developments
- 8.12. Okolab Srl
  - 8.12.1. Overview
  - 8.12.2. Financials
  - 8.12.3. Product portfolio
  - 8.12.4. Business strategy
  - 8.12.5. Recent developments
- 8.13. IKS International
  - 8.13.1. Overview
  - 8.13.2. Financials
  - 8.13.3. Product portfolio
  - 8.13.4. Business strategy
  - 8.13.5. Recent developments
- 8.14. HUNTER SCIENTIFIC LIMITED
  - 8.14.1. Overview
  - 8.14.2. Financials
  - 8.14.3. Product portfolio
  - 8.14.4. Business strategy
  - 8.14.5. Recent developments
- 8.15. LABOTECT GMBH
  - 8.15.1. Overview
  - 8.15.2. Financials
  - 8.15.3. Product portfolio
  - 8.15.4. Business strategy
  - 8.15.5. Recent developments
- 8.16. Olympus Corporation
  - 8.16.1. Overview
  - 8.16.2. Financials
  - 8.16.3. Product portfolio
  - 8.16.4. Business strategy
  - 8.16.5. Recent developments
- 8.17. RI.MOS. srl
  - 8.17.1. Overview
  - 8.17.2. Financials
  - 8.17.3. Product portfolio
  - 8.17.4. Business strategy
  - 8.17.5. Recent developments

List of Figures

1. Market research process
2. Market research methodology
3. Global In Vitro Fertilization (IVF) market revenue, 2017 – 2024(USD Million)
4. Porter’s five forces analysis
5. In Vitro Fertilization (IVF) market attractiveness analysis, by product type segment
6. In Vitro Fertilization (IVF) market attractiveness analysis, by cycle type segment
7. In Vitro Fertilization (IVF) market: market attractiveness analysis, by regional segment
8. Company market share analysis, 2017
9. Global In Vitro Fertilization (IVF) market revenue share by product type, 2017 and 2024
10. Global In Vitro Fertilization (IVF) market revenue share by Instrument, 2017 and 2024
11. Cryosystem, In Vitro Fertilization (IVF) market revenue share by Instrument type, 2017 and 2024
12. Incubators, In Vitro Fertilization (IVF) market revenue share by Instrument type, 2017 and 2024
13. Imaging system, In Vitro Fertilization (IVF) market revenue share by Instrument type, 2017 and 2024
14. Ovum Aspiration Pump, In Vitro Fertilization (IVF) market revenue share by Instrument type, 2017 and 2024
15. Cabinet, In Vitro Fertilization (IVF) market revenue share by Instrument type, 2017 and 2024
16. Micro Manipulator System, In Vitro Fertilization (IVF) market revenue share by Instrument type, 2017 and 2024
17. Sperm Separation System, In Vitro Fertilization (IVF) market revenue share by Instrument type, 2017 and 2024
18. Disposables and Accessories, In Vitro Fertilization (IVF) market revenue share by Instrument type, 2017 and 2024
19. Other instruments, In Vitro Fertilization (IVF) market revenue share by Instrument type, 2017 and 2024
20. Global In Vitro Fertilization (IVF) market revenue share by Reagent & Media, 2017 and 2024
21. Cryopreservation Media, In Vitro Fertilization (IVF) market revenue share by Reagent & Media, 2017 and 2024
22. Ovum Processing Media, In Vitro Fertilization (IVF) market revenue share by Reagent & Media, 2017 and 2024
23. Semen Processing Media, In Vitro Fertilization (IVF) market revenue share by Reagent & Media, 2017 and 2024
24. Embryo Culture Media, In Vitro Fertilization (IVF) market revenue share by Reagent & Media, 2017 and 2024
25. Global In Vitro Fertilization (IVF) market revenue share by cycle type, 2017 and 2024
26. Fresh Donor IVF Cycles, In Vitro Fertilization (IVF) market revenue share by cycle type, 2017 and 2024
27. Fresh Non-donor IVF Cycles, In Vitro Fertilization (IVF) market revenue share by cycle type, 2017 and 2024
28. Frozen Donor IVF Cycles, In Vitro Fertilization (IVF) market revenue share by cycle type, 2017 and 2024
29. Frozen Non-donor IVF Cycles, In Vitro Fertilization (IVF) market revenue share by cycle type, 2017 and 2024

List of Tables

1. In Vitro Fertilization (IVF) market: market snapshot 2. Drivers of global In Vitro Fertilization (IVF) market: impact analysis
3. Restraints of global In Vitro Fertilization (IVF) market: impact analysis
4. North America In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
5. North America In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
6. U.S. In Vitro Fertilization (IVF)market revenue, by product type, 2017 – 2024(USD Million)
7. U.S. In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
8. Rest of North America In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
9. Rest of North America In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
10. Europe In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
11. Europe In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
12. U.K. In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
13. U.K. In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
14. Germany In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
15. Germany In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
16. France In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
17. France In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
18. Italy In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
19. Italy In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
20. Spain In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
21. Spain In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
22. Rest of Europe In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
23. Rest of Europe In Vitro Fertilization (IVF) market revenue, by cycle type area, 2017 – 2024(USD Million)
24. Asia Pacific In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
25. Asia Pacific In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
26. China In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
27. China In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
28. Japan In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
29. Japan In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
30. India In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
31. India In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
32. Southeast Asia In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
33. Southeast Asia In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
34. Rest of Asia Pacific In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
35. Rest of Asia Pacific In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
36. Latin America In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
37. Latin America In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
38. Brazil In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
39. Brazil In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
40. Rest of Latin America In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
41. Rest of Latin America In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
42. Middle East and Africa In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
43. Middle East and Africa In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
44. GCC Countries In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
45. GCC Countries In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
46. South Africa In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
47. South Africa In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)
48. Rest of Middle East and Africa In Vitro Fertilization (IVF) market revenue, by product type, 2017 – 2024(USD Million)
49. Rest of Middle East and Africa In Vitro Fertilization (IVF) market revenue, by cycle type, 2017 – 2024(USD Million)

Methodology

Free Analysis

In vitro fertilization is the technique of assisted reproduction, where male sperm and female egg is fertilized by placing together in a plastic dish or cell culture. The fertilized egg is implanted in the uterus to make an effort to attach and develop the egg inside the female body. The egg, embryos, or sperms are preserved, frozen, and are stored for later use. In 1978, the first IVF baby, Louise Brown was born in the United Kingdom. The in vitro fertilization technique was primarily developed to treat infertility caused by damaged or blocked of fallopian tubes, but now it is used to treat a wide range of infertility problems.

The global in vitro fertilization (IVF) market is segmented as product type, cycle type, and by geography. Based on product type, the in vitro fertilization (IVF) market is segmented into instruments and reagent & media. The instruments segment is further sub-segmented into cryosystem, incubators, imaging system, ovum aspiration pump, cabinet, micromanipulator system, sperm separation system, disposables and accessories, and other instruments. The reagent & media segment is again segmented into cryopreservation media, ovum processing media, semen processing media, and embryo culture media. On the basis of cycle type, the in vitro fertilization (IVF) market is segmented into fresh donor IVF cycles, fresh non-donor IVF cycles, frozen donor IVF cycles, and frozen non-donor IVF cycles.

Global In Vitro Fertilization (IVF) Market

Asia Pacific held a dominant share of the global market for in vitro fertilization (IVF) in the 2017 and is projected to continue with its regional supremacy over the forthcoming years as well. The increasing availability and accessibility of healthcare facilities, growing research and development expenditure, increasing infertility rate, rising prevalence of PCOS, and continuous growth in fertility tourism is expected to propel the growth of in vitro fertilization (IVF) market in the Asia Pacific. Followed by the Asia Pacific is Europe which anticipates holding the second largest share of the global market. The high awareness about the in vitro fertilization (IVF) products, ease of reimbursement policies, and easy availability of in vitro fertilization (IVF) products in the region are significantly contributing towards the growth of the market in Europe.

Some of the key players in the in vitro fertilization (IVF) market are Cooper Surgical, Inc., Thermo Fisher Scientific, Vitrolife, Cook, Irvine Scientific, EMD Serono, Inc., Genea Limited, Esco Group, Rocket Medical plc, Nidacon International AB, Lotus Bio, Eppendorf AG, Okolab Srl, IKS International, Hunter Scientific Limited, Labotect GmbH, Olympus Corporation, and RI.MOS. Srl.